Italia markets open in 4 hours 14 minutes

Dow Jones
39.671,04
-201,95(-0,51%)
Nasdaq
16.801,54
-31,08(-0,18%)
Nikkei 225
38.881,85
+264,75(+0,69%)
EUR/USD
1,0832
+0,0005(+0,04%)
Bitcoin EUR
64.114,14
-551,49(-0,85%)
CMC Crypto 200
1.511,65
-14,76(-0,97%)

NVCR Jun 2024 17.500 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

7,30

0,00

(0,00%)

In data: 09:52AM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in